GIANI , Tommaso

Last name: GIANI

First name: Tommaso

2020 (v1)

Publication

Metadata-only

Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteria

Bassetti, Matteo Pilato, Vincenzo Di Giani, Tommaso

In the last decades, there was an important paucity of agents for adequately treating infections due to metallo-beta-lactamases-producing Gram-negative bacteria (MBL-GNB). Cefiderocol, a novel siderophore cephalosporin showing in vitro activity against MBL-GNB, has been recently marketed, and a combination of aztreonam and ceftazidime/avibactam...

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin /631/326/22/1434 /631/326/325/1506 /631/337/458/1733 /38 /64 /45 /45/70 /45/44 /45/23 article

Cannatelli, Antonio Giani, Tommaso Aiezza, Noemi

No description

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

Deciphering variable resistance to novel carbapenem-based β-lactamase-inhibitor combinations in a multiclonal outbreak by KPC carbapenemase-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam

Di Pilato, Vincenzo Principe, Luigi Andriani, Lilia

Carbapenemase-producing Enterobacterales (CPE) represent a major cause of difficult-to-treat infections worldwide. The novel β-lactam/β-lactamase inhibitor combinations (BLICs), including ceftazidime/avibactam (CZA), meropenem/vaborbactam (MVB), and imipenem/relebactam (IMR), represented a breakthrough to treat some CPE infections. However,...

Uploaded on: February 14, 2024
2017 (v1)

Publication

Metadata-only

Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review

Arena, Fabio Henrici De Angelis, Lucia D'Andrea, Marco Maria

No description

Uploaded on: April 14, 2023

GIANI , Tommaso

Recent uploads